Next Century Growth Investors’s Ligand Pharmaceuticals LGND Stock Holding History

Next Century Growth Investors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.1M	Buy	+95,876	New	+$19M	1.39%	27
2019 Q3	–	Sell	-66,239	Closed	-$4.72M	–	133
2019 Q2	$4.72M	Sell	66,239 -1,704	-3%	-$126K	0.59%	56
2019 Q1	$5.33M	Sell	67,943 -34,021	-33%	-$2.58M	0.71%	56
2018 Q4	$8.63M	Buy	101,964 +29,255	+40%	+$3.12M	1.23%	23
2018 Q3	$12.4M	Sell	72,709 -10,988	-13%	-$1.66M	1.44%	14
2018 Q2	$10.8M	Sell	83,697 -6,134	-7%	-$684K	1.38%	21
2018 Q1	$9.26M	Sell	89,831 -44,199	-33%	-$4.37M	1.23%	31
2017 Q4	$11.4M	Sell	134,030 -10,484	-7%	-$909K	1.42%	25
2017 Q3	$12.3M	Sell	144,514 -47,907	-25%	-$3.79M	1.47%	20
2017 Q2	$14.6M	Sell	192,421 -37,132	-16%	-$2.6M	1.4%	23
2017 Q1	$15.2M	Sell	229,553 -40,854	-15%	-$2.69M	1.28%	21
2016 Q4	$17.1M	Buy	270,407 +2,684	+1%	+$169K	1.05%	33
2016 Q3	$17M	Sell	267,723 -28,646	-10%	-$2.1M	0.78%	44
2016 Q2	$22.1M	Sell	296,369 -208,352	-41%	-$15.5M	1.03%	29
2016 Q1	$33.7M	Buy	504,721 +141,013	+39%	+$8.57M	1.59%	21
2015 Q4	$24.6M	Buy	363,708 +17,338	+5%	+$1.07M	1.06%	28
2015 Q3	$18.5M	Buy	346,370 +84,271	+32%	+$5.11M	0.77%	43
2015 Q2	$16.5M	Sell	262,099 -251,231	-49%	-$13.7M	0.57%	56
2015 Q1	$24.7M	Sell	513,330 -166,866	-25%	-$6.39M	0.87%	32
2014 Q4	$22.6M	Sell	680,196 -103,044	-13%	-$3.35M	0.81%	42
2014 Q3	$23M	Buy	783,240 +369,908	+89%	+$12.3M	0.81%	42
2014 Q2	$16.1M	Sell	413,332 -247,033	-37%	-$10M	0.52%	65
2014 Q1	$27.7M	Sell	660,365 -32,931	-5%	-$1.37M	0.82%	40
2013 Q4	$22.7M	Sell	693,296 -29,203	-4%	-$951K	0.63%	56
2013 Q3	$19.5M	Buy	722,499 +556,340	+335%	+$15.7M	0.56%	53
2013 Q2	$3.88M	Buy	+166,159	New	+$2.99M	0.12%	148

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Next Century Growth Investors's LGND Position: Q1 2026 in Review

Next Century Growth Investors opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2026: 95,876 shares worth $19.1M. The stake represents 1.39% of the portfolio and ranks #27 among its holdings. This is a return to the name: Next Century Growth Investors previously reported a position in LGND as recently as Q2 2019.

Next Century Growth Investors first reported a position in LGND in Q2 2013 and has held it in 26 quarters since. The position peaked at $33.7M in Q1 2016. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Next Century Growth Investors held 95,876 shares of Ligand Pharmaceuticals worth $19.1M as of Q1 2026.
Ligand Pharmaceuticals was a new Next Century Growth Investors position in Q1 2026.
Ligand Pharmaceuticals made up 1.39% of Next Century Growth Investors's portfolio in Q1 2026, its #27 holding.
Next Century Growth Investors first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 26 quarters since.
Next Century Growth Investors's Ligand Pharmaceuticals position peaked at $33.7M in Q1 2016.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Next Century Growth Investors's 13F filing for Q1 2026, filed 14 May 2026.